Wednesday 9 June 2021

Controversial New Alzheimer's Drug: What to Know

aducanumab

As the first Alzheimer's drug approved since 2003, advocates applaud the decision. Critics say the approval was based on inadequate proof that the drug works and balk at the price tag of $56,000 a year.



from WebMD Health https://ift.tt/3iyW0GD

0 comments:

Post a Comment